190 related articles for article (PubMed ID: 26451527)
1. Epithelial and Erythrocyte Microvesicles From Bronchoalveolar Lavage Fluid Are Elevated and Associated With Outcome in Chronic Lung Allograft Dysfunction.
Harms A; Fuehner T; Warnecke G; Haverich A; Gottlieb J; Trummer A
Transplantation; 2015 Nov; 99(11):2394-400. PubMed ID: 26451527
[TBL] [Abstract][Full Text] [Related]
2. Elevated bronchoalveolar lavage eosinophilia correlates with poor outcome after lung transplantation.
Verleden SE; Ruttens D; Vandermeulen E; van Raemdonck DE; Vanaudenaerde BM; Verleden GM; Vos R
Transplantation; 2014 Jan; 97(1):83-9. PubMed ID: 24157472
[TBL] [Abstract][Full Text] [Related]
3. Epithelial cell death markers in bronchoalveolar lavage correlate with chronic lung allograft dysfunction subtypes and survival in lung transplant recipients-a single-center retrospective cohort study.
Levy L; Tigert A; Huszti E; Saito T; Mitsakakis N; Moshkelgosha S; Joe B; Boonstra KM; Tikkanen JM; Keshavjee S; Juvet SC; Martinu T
Transpl Int; 2019 Sep; 32(9):965-973. PubMed ID: 31002407
[TBL] [Abstract][Full Text] [Related]
4. Lung Microvessicles May Hold Clues to Lung Transplant Failure.
Neujahr DC
Transplantation; 2015 Nov; 99(11):2243-4. PubMed ID: 26451528
[No Abstract] [Full Text] [Related]
5. Fibroproliferation in chronic lung allograft dysfunction: Association of mesenchymal cells in bronchoalveolar lavage with phenotypes and survival.
Combs MP; Xia M; Wheeler DS; Belloli EA; Walker NM; Braeuer RR; Lyu DM; Murray S; Lama VN
J Heart Lung Transplant; 2020 Aug; 39(8):815-823. PubMed ID: 32360292
[TBL] [Abstract][Full Text] [Related]
6. BAL neutrophilia in azithromycin-treated lung transplant recipients: Clinical significance.
Vandermeulen E; Verleden SE; Ruttens D; Moelants E; Mortier A; Somers J; Bellon H; Piloni D; Dupont LJ; Van Raemdonck DE; Proost P; Schols D; Vos R; Verleden GM; Vanaudenaerde BM
Transpl Immunol; 2015 Sep; 33(1):37-44. PubMed ID: 26168736
[TBL] [Abstract][Full Text] [Related]
7. BAL Fluid Eosinophilia Associates With Chronic Lung Allograft Dysfunction Risk: A Multicenter Study.
Todd JL; Weber JM; Kelly FL; Neely ML; Mulder H; Frankel CW; Nagler A; McCrae C; Newbold P; Kreindler J; Palmer SM
Chest; 2023 Sep; 164(3):670-681. PubMed ID: 37003354
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary epithelial markers in phenotypes of chronic lung allograft dysfunction.
Levy L; Moshkelgosha S; Huszti E; Hunter S; Renaud-Picard B; Berra G; Kawashima M; Fernandez-Castillo J; Fuchs E; Dianti M; Ghany R; Keshavjee S; Singer LG; Tikkanen J; Martinu T
J Heart Lung Transplant; 2023 Aug; 42(8):1152-1160. PubMed ID: 36963446
[TBL] [Abstract][Full Text] [Related]
9. Bronchoalveolar lavage cytokine-based risk stratification of minimal acute rejection in clinically stable lung transplant recipients.
Levy L; Huszti E; Ahmed M; Ghany R; Hunter S; Moshkelgosha S; Zhang CYK; Boonstra K; Klement W; Tikkanen J; Singer LG; Keshavjee S; Juvet S; Martinu T
J Heart Lung Transplant; 2021 Dec; 40(12):1540-1549. PubMed ID: 34215500
[TBL] [Abstract][Full Text] [Related]
10. Early posttransplant reductions in club cell secretory protein associate with future risk for chronic allograft dysfunction in lung recipients: results from a multicenter study.
Todd JL; Weber JM; Kelly FL; Neely ML; Nagler A; Carmack D; Frankel CW; Brass DM; Belperio JA; Budev MM; Hartwig MG; Martinu T; Reynolds JM; Shah PD; Singer LG; Snyder LD; Weigt SS; Palmer SM
J Heart Lung Transplant; 2023 Jun; 42(6):741-749. PubMed ID: 36941179
[TBL] [Abstract][Full Text] [Related]
11. BALF cytokines in different phenotypes of chronic lung allograft dysfunction in lung transplant patients.
Berastegui C; Gómez-Ollés S; Sánchez-Vidaurre S; Culebras M; Monforte V; López-Meseguer M; Bravo C; Ramon MA; Romero L; Sole J; Cruz MJ; Román A
Clin Transplant; 2017 Mar; 31(3):. PubMed ID: 28008659
[TBL] [Abstract][Full Text] [Related]
12. The prognostic importance of CXCR3 chemokine during organizing pneumonia on the risk of chronic lung allograft dysfunction after lung transplantation.
Shino MY; Weigt SS; Li N; Palchevskiy V; Derhovanessian A; Saggar R; Sayah DM; Huynh RH; Gregson AL; Fishbein MC; Ardehali A; Ross DJ; Lynch JP; Elashoff RM; Belperio JA
PLoS One; 2017; 12(7):e0180281. PubMed ID: 28686641
[TBL] [Abstract][Full Text] [Related]
13. The Prognostic Importance of Bronchoalveolar Lavage Fluid CXCL9 During Minimal Acute Rejection on the Risk of Chronic Lung Allograft Dysfunction.
Shino MY; Weigt SS; Li N; Derhovanessian A; Sayah DM; Saggar R; Huynh RH; Gregson AL; Ardehali A; Ross DJ; Lynch JP; Elashoff RM; Belperio JA
Am J Transplant; 2018 Jan; 18(1):136-144. PubMed ID: 28637080
[TBL] [Abstract][Full Text] [Related]
14. Differential rates of apoptosis in bronchoalveolar lavage and blood of lung transplant patients.
Hodge SJ; Hodge GL; Reynolds PN; Holmes MD
J Heart Lung Transplant; 2005 Sep; 24(9):1305-14. PubMed ID: 16143249
[TBL] [Abstract][Full Text] [Related]
15. Inflammation on bronchoalveolar lavage cytology is associated with decreased chronic lung allograft dysfunction-free survival.
Greenland NY; Deiter F; Calabrese DR; Hays SR; Kukreja J; Leard LE; Kolaitis NA; Golden JA; Singer JP; Greenland JR
Clin Transplant; 2022 Jun; 36(6):e14639. PubMed ID: 35246990
[TBL] [Abstract][Full Text] [Related]
16. Differential cytokine, chemokine and growth factor expression in phenotypes of chronic lung allograft dysfunction.
Verleden SE; Ruttens D; Vos R; Vandermeulen E; Moelants E; Mortier A; Van Raemdonck DE; Proost P; Schols D; Verleden GM; Vanaudenaerde BM
Transplantation; 2015 Jan; 99(1):86-93. PubMed ID: 25050473
[TBL] [Abstract][Full Text] [Related]
17. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction.
Sato M; Waddell TK; Wagnetz U; Roberts HC; Hwang DM; Haroon A; Wagnetz D; Chaparro C; Singer LG; Hutcheon MA; Keshavjee S
J Heart Lung Transplant; 2011 Jul; 30(7):735-42. PubMed ID: 21419659
[TBL] [Abstract][Full Text] [Related]
18. Erythrocyte-derived microvesicles amplify systemic inflammation by thrombin-dependent activation of complement.
Zecher D; Cumpelik A; Schifferli JA
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):313-20. PubMed ID: 24311376
[TBL] [Abstract][Full Text] [Related]
19. Erratic tacrolimus exposure, assessed using the standard deviation of trough blood levels, predicts chronic lung allograft dysfunction and survival.
Gallagher HM; Sarwar G; Tse T; Sladden TM; Hii E; Yerkovich ST; Hopkins PM; Chambers DC
J Heart Lung Transplant; 2015 Nov; 34(11):1442-8. PubMed ID: 26186804
[TBL] [Abstract][Full Text] [Related]
20. Survival determinants in lung transplant patients with chronic allograft dysfunction.
Verleden GM; Vos R; Verleden SE; De Wever W; De Vleeschauwer SI; Willems-Widyastuti A; Scheers H; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM
Transplantation; 2011 Sep; 92(6):703-8. PubMed ID: 21836537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
